SOP Guide for Pharma

Biosimilars: SOP for Microbial Contamination Check During Culture in Bioreactor Operations – V 2.0


Biosimilars: SOP for Microbial Contamination Check During Culture in Bioreactor Operations – V 2.0


Standard Operating Procedure for Microbial Contamination Check During Culture in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/079/2025
Supersedes SOP/BS/079/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standard method for detecting microbial contamination during bioreactor operations in the biosimilar manufacturing process, ensuring timely identification and mitigation in compliance with GMP guidelines.

2. Scope

This SOP applies to all bioreactors (stainless steel and single-use) used for upstream biosimilar production that require routine microbial contamination checks during culture.

3. Responsibilities

  • Process Operators: Collect in-process samples aseptically for microbial testing.
  • Microbiology Analysts: Perform microbial testing, incubation, and reporting.
  • QA Officer: Review reports and initiate CAPA in case of positive results.

4. Accountability

The Microbiology Manager is accountable for ensuring microbial contamination checks are conducted as per this SOP and any deviations are properly documented.

5. Procedure

5.1 Sampling Frequency and Materials

  1. Collect samples once every 24 hours during culture, or as defined in the Batch Manufacturing Record (BMR).
  2. Use sterile syringes or septum ports and sterile sample containers labeled with:
    • Batch No.
    • Date & Time
    • Bioreactor ID

5.2 Sample Collection Procedure

  1. Wipe sampling port with 70% IPA and wear sterile gloves.
  2. Withdraw 5–10 mL of culture fluid using sterile technique.
  3. Transfer immediately to labeled container and send to Microbiology Lab within 30 minutes.
  4. Log collection details in Annexure-1.

5.3 Microbiological Testing

  1. Perform the following tests:
    • Total Aerobic Count (TAMC)
    • Total Yeast and Mold Count (TYMC)
    • Gram Staining
    • Rapid Mycoplasma Detection (if needed)
  2. Inoculate 1 mL sample into TSB and FTM media and incubate at 20–25°C and 30–35°C respectively for 7 days.
  3. Record test results daily for contamination signs (Annexure-2).

5.4 Result Interpretation and Actions

  1. If growth is observed, immediately:
    • Quarantine the bioreactor
    • Collect second confirmatory sample
    • Inform QA and initiate deviation report
  2. If confirmed, terminate batch and initiate CAPA and cleaning validation.
  3. Document all results and corrective measures in Annexure-3.

6. Abbreviations

  • TAMC: Total Aerobic Microbial Count
  • TYMC: Total Yeast and Mold Count
  • CAPA: Corrective and Preventive Action
  • IPA: Isopropyl Alcohol

7. Documents

  1. Sampling Log – Annexure-1
  2. Microbial Test Observation Log – Annexure-2
  3. Deviation and CAPA Record – Annexure-3

8. References

  • USP <61> and <62> – Microbiological Examination
  • WHO TRS 1004 – GMP for Biotech Products
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sampling Log

Date Time Batch No. Reactor ID Collected By Remarks
04/05/2025 09:00 BS-079-B01 BR-03 Rajesh Kumar Normal

Annexure-2: Microbial Test Observation Log

Date Media Type Incubation Temp Observation Analyst
04/05/2025 TSB 30–35°C No Growth Sunita Reddy

Annexure-3: Deviation and CAPA Record

Date Deviation Description Immediate Action CAPA QA Review
04/05/2025 Positive Bacterial Growth Batch Hold Re-training & Sanitation Pending

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added rapid detection method and Annexure-3 CAPA record Compliance Upgrade
Exit mobile version